Gilead posts results of ARTISTRY-1 bictegravir/lenacapavir study
The study, enrolling 689 participants, compared bictegravir/lenacapavir to stable baseline regimens in virologically suppressed people with HIV-1. Results were first posted on ClinicalTrials.gov on October 21, 2026.
Primary source
ClinicalTrials.gov results record, October 21, 2026
Study to Compare Bictegravir/Lenacapavir Versus Current Therapy in People With HIV-1 Who Are Successfully Treated With a Complicated Regimen (ARTISTRY-1)
Read the source: Study to Compare Bictegravir/Lenacapavir Versus Current Therapy in People With HIV-1 Who Are Successfully Treated With a Complicated Regimen (ARTISTRY-1) clinicaltrials.gov
Machine-summarized from the source above; not independently reported. How we use automation